Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial
一项多中心、随机、开放标签的 II 期临床试验（ARST1321）研究了接受术前放化疗（联合或不联合帕唑帕尼）治疗的未切除的大型中度或高度软组织肉瘤患儿和成人患者的病理反应。
期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(20)30325-9
Weiss, Aaron R; Chen, Yen-Lin; Scharschmidt, Thomas J; Chi, Yueh-Yun; Tian, Jing; Black, Jennifer O; Davis, Jessica L; Fanburg-Smith, Julie C; Zambrano, Eduardo; Anderson, James; Arens, Robin; Binitie, Odion; Choy, Edwin; Davis, Justin W; Hayes-Jordan, Andrea; Kao, Simon C; Kayton, Mark L; Kessel, Sandy; Lim, Ruth; Meyer, William H; Million, Lynn; Okuno, Scott H; Ostrenga, Andrew; Parisi, Marguerite T; Pryma, Daniel A; Randall, R Lor; Rosen, Mark A; Schlapkohl, Mary; Shulkin, Barry L; Smith, Ethan A; Sorger, Joel I; Terezakis, Stephanie; Hawkins, Douglas S; Spunt, Sheri L; Wang, Dian
